Cargando…
Alprostadil vs. isosorbide dinitrate in ameliorating angina episodes in patients with coronary slow flow phenomenon: A randomized controlled trial
BACKGROUND: The optimum therapy for coronary slow flow phenomenon (CSFP) stays debatable. This study compared the effectiveness of alprostadil with isosorbide dinitrate in alleviating angina episodes in CSFP patients. METHODS: In this prospective, randomized controlled study, 102 patients with CSFP...
Autores principales: | Zhang, Weifeng, Dai, Jinjie, Shen, Lan, Jiang, Yue, Zheng, Xiaowen, Xu, Ke, Yang, Xiaoxiao, Wang, Xiaolei, Hao, Ziyong, Zhao, Yu, Wang, Dong, Jiang, Lisheng, Qiu, Xingbiao, Shen, Linghong, He, Ben |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9493040/ https://www.ncbi.nlm.nih.gov/pubmed/36158840 http://dx.doi.org/10.3389/fcvm.2022.965364 |
Ejemplares similares
-
Myocardial protective effect of intracoronary administration of nicorandil and alprostadil via targeted perfusion microcatheter in patients undergoing elective percutaneous coronary intervention: A randomized controlled trial
por: Zhang, Weifeng, et al.
Publicado: (2021) -
Coronary MRI with induced vasodilation using isosorbide dinitrate
por: Hu, Peng, et al.
Publicado: (2009) -
Meta-Analysis of Randomized Controlled Trials on the Efficacy of Di'ao Xinxuekang Capsule and Isosorbide Dinitrate in Treating Angina Pectoris
por: Jia, Yongliang, et al.
Publicado: (2012) -
Higher than recommend dosage of sublingual isosorbide dinitrate for treating angina pectoris: a case report and review of the literature
por: Cao, Hong-Yan, et al.
Publicado: (2021) -
Isosorbide dinitrate-hydralazine combination therapy in African Americans with heart failure
por: Echols, Melvin R, et al.
Publicado: (2006)